Hydrochlorothiazide


Thông tin thuốc gốc
Chỉ định và Liều dùng
Oral
Oedema
Adult: 25-100 mg daily in 1-2 divided dose. Max: 200 mg daily. Dose may be administered on alternate days or on 3-5 days each week.
Elderly: >65 years Initially, 12.5 mg daily, titrate as necessary in increments of 12.5 mg.
Child: <6 months 3 mg/kg daily in 2 divided doses; 6 months to <2 years 1-2 mg/kg daily as single or in 2 divided doses. Max: 37.5 mg daily; 2-12 years 1-2 mg/kg daily as single or in 2 divided doses. Max: 100 mg daily.

Oral
Hypertension
Adult: As monotherapy or in combination with other antihypertensives: Initially, 12.5 mg daily, may be increased up to 50 mg daily as necessary. Max: 100 mg daily. Dosage is individualised according to patient response.
Elderly: >65 years Initially, 12.5 mg daily, titrate as necessary in increments of 12.5 mg.
Child: <6 months 3 mg/kg daily in 2 divided doses; 6 months to <2 years 1-2 mg/kg daily as single or in 2 divided doses. Max: 37.5 mg daily; 2-12 years 1-2 mg/kg daily as single or in 2 divided doses. Max: 100 mg daily.
Cách dùng
Should be taken with food.
Chống chỉ định
Hypersensitivity to sulfonamide-derived drugs. Anuria.
Thận trọng
Patient with fluid or electrolyte imbalance, Addison’s disease, ascites due to cirrhosis, prediabetes or diabetes mellitus, hypercholesterolaemia, bronchial asthma, SLE, gout. Postoperative period after bariatric surgery. Hepatic and severe renal impairment. Children and elderly. Pregnancy and lactation.
Tác dụng không mong muốn
Significant: Skin photosensitivity; increased risk of non-melanoma skin cancer, basal cell carcinoma, squamous cell carcinoma; electrolyte imbalance (e.g. hyponatraemia, hypochloraemic alkalosis, hypokalaemia, hypomagnesaemia, hypercalcaemia), hyperuricaemia, hyperglycaemia, SLE exacerbation or activation, hypersensitivity reactions. Rarely, acute transient myopia, acute angle-closure glaucoma.
Blood and lymphatic system disorders: Leucopenia, agranulocytosis, thrombocytopenia, aplastic anaemia, haemolytic anaemia.
Eye disorders: Blurred vision (transient), xanthopsia.
Gastrointestinal disorders: Gastric irritation, nausea, vomiting, abdominal cramps, diarrhoea, constipation, pancreatitis, sialoadenitis.
General disorders and administration site conditions: Weakness.
Hepatobiliary disorders: Jaundice.
Metabolism and nutrition disorders: Anorexia.
Musculoskeletal and connective tissue disorders: Muscle spasm.
Nervous system disorders: Dizziness, vertigo, paraesthesia, headache.
Renal and urinary disorders: Renal dysfunction, interstitial nephritis, glycosuria.
Skin and subcutaneous tissue disorders: Alopecia, skin rash, toxic epidermal necrolysis, urticaria.
Vascular disorders: Hypotension, orthostatic, hypotension.
Thông tin tư vấn bệnh nhân
This medicine may cause photosensitivity reactions, avoid exposure to direct sunlight and UV light and apply sunscreen when going outdoors.
Chỉ số theo dõi
Monitor serum electrolytes (e.g. Na, K), blood pressure, BUN, creatinine. Assess skin for photosensitivity and skin cancer; visual acuity and ocular pain.
Quá liều
Symptoms: Electrolyte depletion (e.g. hypokalaemia, hypochloraemia, hyponatraemia), and dehydration. Management: Symptomatic and supportive treatment. May induce emesis or perform gastric lavage for recent ingestion. Administration of activated charcoal may be given within 1 hour of ingestion. Correct dehydration, electrolyte imbalance, hepatic coma, and hypotension by established procedures. Give oxygen or artificial respiration for respiratory impairment as needed.
Tương tác
May reduce renal clearance and enhance the toxic effect of lithium. Potentiation of orthostatic hypotension with alcohol, barbiturates, or narcotics. May reduce therapeutic effect of antidiabetics. Additive effect with other antihypertensive drugs. Reduced absorption with cholestyramine and colestipol resins. Enhanced hypokalaemic effect with corticosteroids, ACTH. May decrease arterial response to pressor amines (e.g. norepinephrine). May increase response to neuromuscular blocking action of skeletal muscle relaxants (e.g. tubocurarine).
Tương tác với thức ăn
May potentiate orthostatic hypotension with alcohol.
Ảnh hưởng đến kết quả xét nghiệm
May interfere with parathyroid function tests. May cause false positive result to aldosterone/renin ratio (ARR).
Tác dụng
Description:
Mechanism of Action: Hydrochlorothiazide is a thiazide diuretic which acts by inhibiting Na reabsorption in the distal tubules, thereby causing increased excretion of Na, K, hydrogen ions, and water. The hypotensive effects are initially due to volume reduction, but the persisting effect includes other undetermined mechanisms that reduce peripheral resistance.
Onset: Diuresis: Approx 2 hours. Peak effect: Approx 4 hours.
Duration: 6-12 hours.
Pharmacokinetics:
Absorption: Rapidly and fairly well absorbed from the gastrointestinal tract. Bioavailability: Approx 65-75%. Time to peak plasma concentration: Approx 1-5 hours.
Distribution: Crosses placenta, enters breast milk. Volume of distribution: 3.6-7.8 L/kg. Plasma protein binding: Approx 40-68%.
Excretion: Mainly via urine (≥61% as unchanged drug). Elimination half-life: Approx 5-15 hours.
Đặc tính

Chemical Structure Image
Hydrochlorothiazide

Source: National Center for Biotechnology Information. PubChem Compound Summary for CID 3639, Hydrochlorothiazide. https://pubchem.ncbi.nlm.nih.gov/compound/Hydrochlorothiazide. Accessed Oct. 24, 2023.

Bảo quản
Store between 20-25°C. Protect from light and moisture.
Phân loại MIMS
Thuốc lợi tiểu
Phân loại ATC
C03AA03 - hydrochlorothiazide ; Belongs to the class of low-ceiling thiazide diuretics.
Tài liệu tham khảo
Anon. Hydrochlorothiazide. AHFS Clinical Drug Information [online]. Bethesda, MD. American Society of Health-System Pharmacists, Inc. https://www.ahfscdi.com. Accessed 01/09/2022.

Anon. Hydrochlorothiazide. Lexicomp Online. Hudson, Ohio. Wolters Kluwer Clinical Drug Information, Inc. https://online.lexi.com. Accessed 01/09/2022.

Apo-Hydrochlorothiazide 25 mg and 50 mg Tablets (Apotex Inc.). National Pharmaceutical Regulatory Agency - Ministry of Health Malaysia. https://www.npra.gov.my. Accessed 01/09/2022.

Buckingham R (ed). Hydrochlorothiazide. Martindale: The Complete Drug Reference [online]. London. Pharmaceutical Press. https://www.medicinescomplete.com. Accessed 01/09/2022.

Hydrochlorothiazide Capsules (Aurobindo Pharma Limited). DailyMed. Source: U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed. Accessed 01/09/2022.

Hydrochlorothiazide Tablets (Teva Pharmaceuticals). DailyMed. Source: U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed. Accessed 01/09/2022.

Joint Formulary Committee. Hydrochlorothiazide. British National Formulary [online]. London. BMJ Group and Pharmaceutical Press. https://www.medicinescomplete.com. Accessed 01/09/2022.

Thông báo miễn trừ trách nhiệm: Thông tin này được MIMS biên soạn một cách độc lập dựa trên thông tin của Hydrochlorothiazide từ nhiều nguồn tài liệu tham khảo và được cung cấp chỉ cho mục đích tham khảo. Việc sử dụng điều trị và thông tin kê toa có thể khác nhau giữa các quốc gia. Vui lòng tham khảo thông tin sản phẩm trong MIMS để biết thông tin kê toa cụ thể đã qua phê duyệt ở quốc gia đó. Mặc dù đã rất nỗ lực để đảm bảo nội dung được chính xác nhưng MIMS sẽ không chịu trách nhiệm hoặc nghĩa vụ pháp lý cho bất kỳ yêu cầu bồi thường hay thiệt hại nào phát sinh do việc sử dụng hoặc sử dụng sai các thông tin ở đây, về nội dung thông tin hoặc về sự thiếu sót thông tin, hoặc về thông tin khác. © 2024 MIMS. Bản quyền thuộc về MIMS. Phát triển bởi MIMS.com
  • Apo-Hydro
  • Do-hydro
  • Hydrochlorothiazide JSC Schelkovo
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in